CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.06
52W Range
$0.05 - $12.80
50D Avg
$0.13
200D Avg
$0.63
Market Cap
$7.59M
Avg Vol (3M)
$72.83M
Beta
-0.46
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.